| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 112828-00-9 | Calcipotriol | C27H40O3 |
| 112828-09-8 | (1alpha,3beta,5Z,7E,24R)-24-Cyclopropyl-9,10-secochola-5,7,10(19)-triene-1,3,24-triol | C27H42O3 |
| 112828-12-3 | (alphaS,1R,3aS,4E,7aR)-4-[(2E)-[(5S)-5-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-alpha,7a-dimethyl-1H-indene-1-acetaldehyde | C28H46O2Si |
| 112830-95-2 | (6aR,10aR)-3-(1,1-Dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol | C25H38O3 |
| 112835-62-8 | Ethyl 2-((1R,2S)-2-hydroxy-1,2-diphenylethylamino)acetate | C18H21NO3 |
| 112839-95-9 | (S)-3-Aminooxetan-2-one 4-methylbenzenesulfonate | C3H5NO2.C7H8O3S |
| 112849-14-6 | (1alpha,3beta,5Z,7E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19)-triene-1,3,24-triol | C27H42O3 |
| 112849-17-9 | (2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one | C39H66O3Si2 |
| 112849-27-1 | Bis-TBDMS-trans-calcipotriol | C39H68O3Si2 |
| 112854-88-3 | 3-(N-Acetoaceto)amino-4-methoxyacetanilide | C13H16N2O4 |
| 112875-50-0 | Ustilaginoidin F | C28H22O9 |
| 112875-61-3 | (1alpha,3beta,5Z,7E,22E,24S)-24-Cyclopropyl-1,3-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-9,10-secochola-5,7,10(19),22-tetraen-24-ol | C39H68O3Si2 |
| 112881-51-3 | 4'-(4-Pyridyl)-2,2':6',2''-terpyridine | C20H14N4 |
| 112883-29-1 | (R)-N-Fmoc-D-tyrosine | C24H21NO5 |
| 112883-39-3 | Fmoc-D-Aspartic acid beta-tert-butyl ester | C23H25NO6 |
| 112883-40-6 | Fmoc-D-methionine | C20H21NO4S |
| 112883-41-7 | Fmoc-D-Norleucine | C21H23NO4 |
| 112883-42-8 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-norleucine | C22H25NO4 |
| 112883-43-9 | (S)-N-Fmoc-3-(2-naphthyl)alanine | C28H23NO4 |
| 112885-41-3 | Mosapride | C21H25ClFN3O3 |
| 112885-42-4 | Mosapride citrate | C21H25ClFN3O3.C6H8O7;C27H33ClFN3O10 |
| 112887-25-9 | 2-Fluoro-5-sulfamoylbenzoic acid | C7H6FNO4S |
| 112887-68-0 | Raltitrexed | C21H22N4O6S |
| 112888-43-4 | 6-Bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one | C10H9BrN2O |
| 112888-76-3 | tert-Butyl 4-(2-propynylamino)benzoate | C14H17NO2 |
| 112889-02-8 | Diethyl N-[5-methylamino-2-thenoyl]-L-glutamate | C15H22N2O5S |
| 112892-88-3 | 4-Carboxaldehydebenzocyclobutene | C9H8O |
| 112897-97-9 | trans-3,4-Difluorocinnamic acid | C9H6F2O2 |
| 112897-99-1 | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]cytidine | C30H31N3O7 |
| 112898-00-7 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-glutamine | C20H20N2O5 |
| 112898-15-4 | Adenosine 5'-(tetrahydrogen triphosphate) 3'-(4-benzoylbenzoate) compd. with N,N-diethylethanamine | C24H24N5O15P3.C6H15N |
| 112898-17-6 | L-Lysyl-L-histidylglycinamide trihydrochloride | C14H25N7O3.3(HCl) |
| 112898-18-7 | Boc-D-aspartic acid 4-cyclohexyl ester | C15H25NO6 |
| 112898-23-4 | N-[(1,1-Dimethylethoxy)carbonyl]-3-(methylthio)-L-valine dicyclohexylammonium salt | C12H23N.C11H21NO4S |
| 112898-33-6 | 2,5-Difluorocinnamic acid | C9H6F2O2 |
| 112898-42-7 | Imipramine-d3 | C19H24N2 |
| 112901-68-5 | Anifostine trihydrate | C5H15N2O3PS.3(H2O) |
| 112904-73-1 | 3,4-Dihydro-8-methoxy-2H-1-benzopyran-3-amine | C10H13NO2 |
| 112913-63-0 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-tryptophan | C27H24N2O4 |
| 112913-94-7 | 2-Acetylamidomethyl-4-(4-fluorobenzyl)morpholine | C14H19FN2O2 |
| 112914-13-3 | 2-Aminomethy-4-(4-fluorobenzyl)morpholine | C12H17FN2O |
| 112918-82-8 | N-(9-Fluorenylmethoxycarbonyl)iminodiacetic acid | C19H17NO6 |
| 112924-45-5 | Dexanabinol | C25H38O3 |
| 112926-00-8 | Silica gel | SiO2 |
| 112926-02-0 | Indo 1-AM | C47H51N3O22 |
| 112930-39-9 | 3-Bromo-5-isopropylbenzoic acid | C10H11BrO2 |
| 112941-26-1 | o-Carbomethoxybenzyl sulfonamide | C9H11NO4S |
| 112941-35-2 | 2-(Trifluoromethyl)benzylsulfonamide | C8H8F3NO2S |
| 112945-52-5 | Silicon dioxide | SiO2 |
| 112952-20-2 | 1-(2-Chloroethyl)-4-(2-propenyl)piperazine | C9H17ClN2 |